12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Deals

pSivida deal

pSivida said an undisclosed global pharmaceutical company will evaluate pSivida's Tethadur protein/antibody delivery technology and

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >